- Home
- OCGN vs AFRI Comparison
OCGN vs AFRI Comparison
Compare OCGN & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- AFRI
- Stock Information
- Founded
- OCGN 2013
- AFRI 1943
- Country
- OCGN United States
- AFRI Gibraltar
- Employees
- OCGN N/A
- AFRI N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- AFRI Packaged Foods
- Sector
- OCGN Health Care
- AFRI Consumer Staples
- Exchange
- OCGN Nasdaq
- AFRI Nasdaq
- Market Cap
- OCGN 246.8M
- AFRI 275.5M
- IPO Year
- OCGN N/A
- AFRI N/A
- Fundamental
- Price
- OCGN $0.89
- AFRI $10.22
- Analyst Decision
- OCGN Strong Buy
- AFRI
- Analyst Count
- OCGN 3
- AFRI 0
- Target Price
- OCGN $5.67
- AFRI N/A
- AVG Volume (30 Days)
- OCGN 6.1M
- AFRI 10.7K
- Earning Date
- OCGN 11-08-2024
- AFRI 01-14-2025
- Dividend Yield
- OCGN N/A
- AFRI N/A
- EPS Growth
- OCGN N/A
- AFRI N/A
- EPS
- OCGN N/A
- AFRI N/A
- Revenue
- OCGN $4,700,000.00
- AFRI $305,476,000.00
- Revenue This Year
- OCGN N/A
- AFRI N/A
- Revenue Next Year
- OCGN N/A
- AFRI N/A
- P/E Ratio
- OCGN N/A
- AFRI N/A
- Revenue Growth
- OCGN N/A
- AFRI 5.42
- 52 Week Low
- OCGN $0.49
- AFRI $9.63
- 52 Week High
- OCGN $2.11
- AFRI $12.00
- Technical
- Relative Strength Index (RSI)
- OCGN 54.92
- AFRI 49.76
- Support Level
- OCGN $0.79
- AFRI $10.01
- Resistance Level
- OCGN $0.88
- AFRI $10.36
- Average True Range (ATR)
- OCGN 0.08
- AFRI 0.28
- MACD
- OCGN 0.01
- AFRI 0.01
- Stochastic Oscillator
- OCGN 65.97
- AFRI 44.21
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.